A new platelet alloantigen (Efs^2a) on glycoprotein GPIIIa leading to neonatal alloimmune thrombocytopenia.

IF 2.5 3区医学 Q2 HEMATOLOGY

Transfusion Pub Date : 2024-08-01 Epub Date: 2024-06-25 DOI:10.1111/trf.17933

Gérald Bertrand, Yannic Danger, Franck Verite, Mireille Sarpentier Guibourg, Justine Coombs, Virginie Renac

引用次数: 0

查看原文本刊更多论文

糖蛋白 GPIIIa 上的一种新的血小板同种抗原（Efs2a）导致新生儿同种免疫血小板减少症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Transfusion 医学-血液学

CiteScore

4.70

自引率

20.70%

发文量

426

审稿时长

1 months

期刊介绍： TRANSFUSION is the foremost publication in the world for new information regarding transfusion medicine. Written by and for members of AABB and other health-care workers, TRANSFUSION reports on the latest technical advances, discusses opposing viewpoints regarding controversial issues, and presents key conference proceedings. In addition to blood banking and transfusion medicine topics, TRANSFUSION presents submissions concerning patient blood management, tissue transplantation and hematopoietic, cellular, and gene therapies.

A new platelet alloantigen (Efs2a) on glycoprotein GPIIIa leading to neonatal alloimmune thrombocytopenia.

A new platelet alloantigen (Efs^2a) on glycoprotein GPIIIa leading to neonatal alloimmune thrombocytopenia.